Hope this question isn't too odd; I'm sure it's rather premature. However, I'm asking on behalf of a physician who has been following Qsymia for some time. He has prescribing similar or the same combination of pharmaceutical agents for pts for some time for the purpose of alleviating dysthymia while also promoting weight loss. So he would appreciate learning more about the new product as soon as possible. He also really enjoys giving talks for his colleagues, but hasn't felt enthused about a drug in some time, so has not accepted any speaking engagements recently.
Does anyone have any advice about helping him with the above matter? I did submit his practice information under the Stendra web form, as he does occasionally prescribe that class of medications as well, so that he may be contacted by any area reps. Anything else? Thank you.
Does anyone have any advice about helping him with the above matter? I did submit his practice information under the Stendra web form, as he does occasionally prescribe that class of medications as well, so that he may be contacted by any area reps. Anything else? Thank you.